Infovista names José Duarte as Chief Executive Officer
Newly appointed CEO to strengthen position for next stage of growth and scale
PARIS and ASHBURN, Va., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Infovista, the leader in modern network performance, today announced that its Board of Directors has appointed José Duarte as Chief Executive Officer effective immediately. Current CEO Philippe Ozanian will assume the role of Senior Advisor.
“This is the perfect time for José Duarte to become Infovista’s next CEO. We’ve selected a very strong leader at a pivotal time when Infovista is positioned for accelerated growth in the SD-WAN and 5G spaces,” said Gilles Rigal, Infovista Chairman and Partner at Apax Partners. “José is unique in his ability to transform teams into an engine of growth and realize maximum potential.”
Duarte has served as an active non-executive director at Infovista since October 2016. He brings deep expertise in managing businesses at scale, growing and transforming operations and demonstrable strategic thinking to his role as CEO.
He has an extensive background leading publicly listed and privately held, high-growth global technology companies. Previously, he was CEO of Infinitas Learning, CEO of Unit4 and served at SAP for 20 years. He was the founder of SAP Portugal and evolved through the ranks, having served as President Global Services and Corporate Officer, President EMEA and India and President Latin America. Duarte has also developed extensive experience as a non-executive director, primarily in private equity backed companies. He currently holds non-executive director positions in ProAlpha and Gelato.
“It’s a great time to be joining Infovista,” said Duarte. “The opportunity that lies ahead to capitalize on the fast-growing demand for SD-WAN and 5G solutions and further grow in key sectors worldwide is immense. The ability to lead this next phase of growth is both exhilarating and humbling.”
Infovista also announced that Philippe Ozanian, currently CEO, will assume the role of Senior Advisor to the CEO. He will devote his time to supporting Duarte and ensuring business continuity during this transition. Ozanian has served as CEO of Infovista since 2008.
“With José taking over the role of CEO, with the advisory support of Philippe, the board is very confident Infovista has the leadership to drive its success for the next chapter,” added Rigal.
For more information on Infovista, visit https://www.infovista.com.
Infovista, the leader in modern network performance, provides complete visibility and unprecedented control over modern networks and their applications. Infovista delivers brilliant user experiences and maximum value for networks and applications. At the core of its approach are data and analytics, to give service providers and enterprises real-time insights to make critical business decisions. Infovista offers a comprehensive line of solutions from the radio network to enterprise to device throughout the lifecycle of a network. No other solutions provider has this totality of vision. More than 1,500 enterprises and service providers around the world—including 250 of the world’s top mobile network operators—rely on Infovista. Know Your Network with Infovista.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d484576f-7c7f-4803-8788-1f027efd8d39
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Mitsubishi Heavy Industries to Acquire Canadair Regional Jet Program from Bombardier Inc.25.6.2019 14:00:00 CEST | Pressemelding
MHI now positioned to transform and lead the underserved regional jet business , with bolster ed customer support services Key step in MHI’s strategy of expanding its aircraft business globally, with a mid-term focus on North America Completes Bombardier’s aerospace transformation and refocus on business aviation TOKYO and MONTRÉAL, June 25, 2019 (GLOBE NEWSWIRE) -- Mitsubishi Heavy Industries, Ltd (MHI) (TOKYO:7011) and Bombardier Inc (TSX: BBD.B) announced today they have entered into a definitive agreement, whereby MHI will acquire Bombardier’s regional jet program for a cash consideration of $550 million USD, payable to Bombardier upon closing, and the assumption by MHI of liabilities amounting to approximately $200 million USD. Under the agreement, Bombardier’s net beneficial interest in the Regional Aircraft Securitization Program (RASPRO), which is valued at approximately $180 million USD, will be transferred to MHI. Pursuant to the agreement, MHI will acquire the maintenance, s
VSBLTY SELECTED BY ENERGETIKA TECHNOLOGIES TO PROVIDE CROWD ANALYTICS TO ENHANCE SAFETY LIGHTING & SECURITY THROUGHOUT LATIN AMERICA25.6.2019 13:44:00 CEST | Pressemelding
Philadelphia, PA, June 25, 2019 (GLOBE NEWSWIRE) -- VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF), a leading retail software and technology company, is teaming with Energetika, an international provider of “intelligent lighting” solutions, to install safety lighting and integrated security to Mexico City, and other Latin American cities designated as a “Smart City.” Accessibility, habitability, sustainability, air quality, noise levels, energy, health and economic vitality are among the elements necessary to be selected as a “Smart City.” Energetika is a leading provider of smart lighting solutions for economically efficient applications that incorporate security. Energetika chose VSBLTY to provide security technology that includes crowd analytics and facial recognition for residential, commercial and governmental applications. VSBLTY technology provides enhanced customer engagement and audience measurement using machine learning and computer vision. Its in
ALLDATA Signs European Licensing Agreement with Honda25.6.2019 06:00:00 CEST | Pressemelding
ALLDATA continues to meet demand for OEM repair information on the most advanced vehicle technologies in the European market ELK GROVE, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- ALLDATA Europe GmbH, an affiliate of ALLDATA LLC, an AutoZone company, has signed an agreement with Honda Motor Europe Ltd., to republish Honda repair and maintenance information for cars. The addition of Honda brings the total number of brands in ALLDATA Repair to 23. With more than 1,000 models, ALLDATA delivers the most comprehensive source of manufacturer repair procedures, instructions, and diagrams to the independent aftermarket. ALLDATA Repair is uniquely positioned to provide technicians with repair information required to complete even the most difficult repair jobs facing workshops today. Garages rely on ALLDATA Repair to provide OEM information to diagnose, maintain and repair the most innovative technologies to manufacturer standards. “With the addition of Honda, ALLDATA Repair can now serve more ve
ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies24.6.2019 23:30:00 CEST | Pressemelding
LYON, France and CAMBRIDGE, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (ERYTECH) (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells (RBCs), announced today that it has entered into an agreement with SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments in multiple therapeutic areas, to advance novel RBC-based therapeutics for immune modulation . Under the terms of the agreement, ERYTECH has granted to SQZ an exclusive worldwide license to develop antigen-specific immune modulating therapies employing RBC-based approaches. Combining SQZ’s proprietary and versatile cell engineering platform, Cell Squeeze®, with ERYTECH’s intellectual property related to RBC-based therapeutics is intended to allow for the rapid development of a broad pipeline of novel immunomodulatory products addressing multiple indications. ERYTECH is eligible to rec
Forterra Announces Leadership Appointments24.6.2019 22:24:00 CEST | Pressemelding
Construction Materials Veteran Karl H. Watson, Jr. Named Chief Executive Officer Forterra Board Member John McPherson Appointed Lead Director and Vice Chairman of the Board Company Reaffirms Full Year 2019 Outlook IRVING, Texas, June 24, 2019 (GLOBE NEWSWIRE) -- Forterra, Inc. (“Forterra” or the “Company”) (NASDAQ:FRTA), a leading manufacturer of water and drainage infrastructure pipe and products in the United States and Eastern Canada, today announced that Karl H. Watson, Jr. has been appointed Chief Executive Officer and a member of the Forterra Board of Directors. Mr. Watson succeeds Jeff Bradley, who has stepped down as CEO and a director to pursue other opportunities. Mr. Watson brings over 30 years of global experience in the construction materials industry and a track record of effectively leading through numerous business cycles and improving financial and operational results. He most recently served as Executive Vice President and Chief Operating Officer at Summit Materials,
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman24.6.2019 17:35:00 CEST | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it has appointed Patrick J. Balthrop, Sr. as Chairman of its board of directors. The current Chairman, Mr. Richard A. Sandberg, will remain a member of the board. “On behalf of the Company and the board of directors I would like to thank our former Chairman, Richard Sandberg, for his service,” said Dr. Peter Wrighton-Smith, CEO of Oxford Immunotec. “In the decade that he served as Chairman, the Company has undergone a profound transformation, and Mr. Sandberg’s guidance and leadership has made an extraordinary contribution to Oxford Immunotec’s success. We look forward to continuing to benefit from his skills and his knowledge of the Company with his ongoing service as a Non-Executive Director.” “We are very pleased to have Mr. Balthrop assume the role of Chairman,” continued Dr. Wrigh